Gilead Sciences DEF 14A: Executive Pay & Governance Details

Ticker: GILD · Form: DEF 14A · Filed: 2024-03-28T00:00:00.000Z

Sentiment: neutral

Topics: executive-compensation, governance, proxy-statement

TL;DR

Gilead's DEF 14A is out, detailing exec pay and board recs for shareholders.

AI Summary

Gilead Sciences, Inc. filed its DEF 14A on March 28, 2024, detailing executive compensation and corporate governance matters for the fiscal year ending December 31, 2023. The filing includes information on compensation for its principal executive officers and directors, as well as details on shareholder proposals and board recommendations.

Why It Matters

This filing provides shareholders with crucial information regarding executive compensation and board decisions, enabling informed voting on important corporate matters.

Risk Assessment

Risk Level: low — This is a routine annual filing (DEF 14A) that discloses executive compensation and governance information, not indicative of immediate operational or financial risk.

Key Numbers

20240328 — Filing Date (Date the DEF 14A was filed with the SEC)
20240508 — Period of Report (The period the filing pertains to, indicating the date as of which information is reported.)
1231 — Fiscal Year End (Indicates the end of Gilead Sciences' fiscal year.)

Key Players & Entities

GILEAD SCIENCES, INC. (company) — Filer of the DEF 14A
0000882095 (company) — Central Index Key for Gilead Sciences
333 LAKESIDE DR, FOSTER CITY, CA 94404 (company) — Business and mailing address for Gilead Sciences

FAQ

What is the primary purpose of a DEF 14A filing?

A DEF 14A filing, also known as a Definitive Proxy Statement, is used to solicit proxies from shareholders for an upcoming annual or special meeting of shareholders. It provides detailed information about matters to be voted on, including director elections, executive compensation, and other corporate actions.

When did Gilead Sciences file this DEF 14A?

Gilead Sciences filed this DEF 14A on March 28, 2024.

What fiscal year does this filing primarily cover?

This filing primarily covers the fiscal year ending December 31, 2023, as indicated by the reporting periods mentioned.

Where is Gilead Sciences, Inc. headquartered?

Gilead Sciences, Inc. is headquartered at 333 Lakeside Dr, Foster City, CA 94404.

What is Gilead Sciences' Standard Industrial Classification (SIC) code?

Gilead Sciences' SIC code is 2836, which corresponds to Biological Products (No Diagnostic Substances).

From the Filing

0001308179-24-000348.txt : 20240328 0001308179-24-000348.hdr.sgml : 20240328 20240328160724 ACCESSION NUMBER: 0001308179-24-000348 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 222 CONFORMED PERIOD OF REPORT: 20240508 FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES, INC. CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 24798885 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: GILEAD SCIENCES INC DATE OF NAME CHANGE: 19930328 DEF 14A 1 lgild2024_def14a.htm GILEAD SCIENCES, INC. - DEF 14A false Gilead Sciences, Inc. 0000882095 DEF 14A 0000882095 2023-01-01 2023-12-31 0000882095 gild:MrODayMember 2023-01-01 2023-12-31 0000882095 gild:MrODayMember 2022-01-01 2022-12-31 0000882095 2022-01-01 2022-12-31 0000882095 gild:MrODayMember 2021-01-01 2021-12-31 0000882095 2021-01-01 2021-12-31 0000882095 gild:MrODayMember 2020-01-01 2020-12-31 0000882095 2020-01-01 2020-12-31 0000882095 ecd:PeoMember gild:LessSummaryCompensationTableReportedValueOfEquityAwardsMember 2023-01-01 2023-12-31 0000882095 ecd:PeoMember gild:PlusEquityAwardAdjustmentsMember 2023-01-01 2023-12-31 0000882095 ecd:PeoMember gild:LessSummaryCompensationTableReportedValueOfEquityAwardsMember 2022-01-01 2022-12-31 0000882095 ecd:PeoMember gild:PlusEquityAwardAdjustmentsMember 2022-01-01 2022-12-31 0000882095 ecd:PeoMember gild:LessSummaryCompensationTableReportedValueOfEquityAwardsMember 2021-01-01 2021-12-31 0000882095 ecd:PeoMember gild:PlusEquityAwardAdjustmentsMember 2021-01-01 2021-12-31 0000882095 ecd:PeoMember gild:LessSummaryCompensationTableReportedValueOfEquityAwardsMember 2020-01-01 2020-12-31 0000882095 ecd:PeoMember gild:PlusEquityAwardAdjustmentsMember 2020-01-01 2020-12-31 0000882095 ecd:PeoMember gild:YearEndFairValueOfEquityAwardsGrantedDuringTheYearMember 2023-01-01 2023-12-31 0000882095 ecd:PeoMember gild:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember 2023-01-01 2023-12-31 0000882095 ecd:PeoMember gild:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember 2023-01-01 2023-12-31 0000882095 ecd:PeoMember gild:ValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValueMember 2023-01-01 2023-12-31 0000882095 ecd:PeoMember gild:TotalEquityAwardAdjustmentsMember 2023-01-01 2023-12-31 0000882095 ecd:PeoMember gild:YearEndFairValueOfEquityAwardsGrantedDuringTheYearMember 2022-01-01 2022-12-31 0000882095 ecd:PeoMember gild:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember 2022-01-01 2022-12-31 0000882095 ecd:PeoMember gild:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember 2022-01-01 2022-12-31 0000882095 ecd:PeoMember gild:ValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValueMember 2022-01-01 2022-12-31 0000882095 ecd:PeoMember gild:TotalEquityAwardAdjustmentsMember 2022-01-01 2022-12-31 0000882095 ecd:PeoMember gild:YearEndFairValueOfEquityAwardsGrantedDuringTheYearMember 2021-01-01 2021-12-31 0000882095 ecd:PeoMember gild:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember 2021-01-01 2021-12-31 0000882095 ecd:PeoMember gild:YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYearMember 2021-01-01 2021-12-31 0000882095 ecd:PeoMember gild:ValueOfDividendEquivalentsAccruedOrOtherEarningsPaidOnStockAwardsNotOtherwiseReflectedInFairValueMember 2021-0